The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used (Q73571951)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2000

Language	Label	Description	Also known as
English	The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used	scientific article published on 01 April 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

Philippe De Deurwaerdère

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

G Lucas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Caccia

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Umberto Spampinato

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1053-1063

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Pharmacological actions of the atypical antipsychotic drug clozapine: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

5-HT2 receptor subtypes: a family re-united?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Elevation of plasma concentrations of haloperidol after the addition of fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Serotonin-dopamine interaction and its relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Newer antidepressants and the cytochrome P450 system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Modulatory role of serotonin in neural information processing: implications for human psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Serotonin-dopamine interactions in the nigrostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900193-8

7 January 2021

Identifiers

10.1016/S0028-3908(99)00193-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727716%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73571951&oldid=2225946096"